nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0533	0.0809	CbGbCtD
Rivastigmine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0501	0.0761	CbGbCtD
Rivastigmine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0501	0.0761	CbGbCtD
Rivastigmine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0453	0.0688	CbGbCtD
Rivastigmine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0453	0.0688	CbGbCtD
Rivastigmine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0391	0.0594	CbGbCtD
Rivastigmine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.038	0.0577	CbGbCtD
Rivastigmine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0343	0.0521	CbGbCtD
Rivastigmine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0343	0.0521	CbGbCtD
Rivastigmine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0339	0.0515	CbGbCtD
Rivastigmine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0319	0.0484	CbGbCtD
Rivastigmine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0319	0.0484	CbGbCtD
Rivastigmine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0288	0.0438	CbGbCtD
Rivastigmine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0288	0.0438	CbGbCtD
Rivastigmine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0249	0.0378	CbGbCtD
Rivastigmine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0241	0.0367	CbGbCtD
Rivastigmine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0218	0.0332	CbGbCtD
Rivastigmine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0218	0.0332	CbGbCtD
Rivastigmine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0209	0.0318	CbGbCtD
Rivastigmine—BCHE—blood plasma—acquired immunodeficiency syndrome	0.000574	0.105	CbGeAlD
Rivastigmine—ACHE—spinal cord—acquired immunodeficiency syndrome	0.000412	0.0754	CbGeAlD
Rivastigmine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000387	0.0707	CbGeAlD
Rivastigmine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00038	0.0696	CbGeAlD
Rivastigmine—BCHE—skin of body—acquired immunodeficiency syndrome	0.000276	0.0505	CbGeAlD
Rivastigmine—ACHE—brain—acquired immunodeficiency syndrome	0.000266	0.0486	CbGeAlD
Rivastigmine—ACHE—lymph node—acquired immunodeficiency syndrome	0.000257	0.0469	CbGeAlD
Rivastigmine—BCHE—digestive system—acquired immunodeficiency syndrome	0.000221	0.0404	CbGeAlD
Rivastigmine—BCHE—blood—acquired immunodeficiency syndrome	0.00021	0.0385	CbGeAlD
Rivastigmine—BCHE—bone marrow—acquired immunodeficiency syndrome	0.000204	0.0372	CbGeAlD
Rivastigmine—BCHE—spinal cord—acquired immunodeficiency syndrome	0.000203	0.0371	CbGeAlD
Rivastigmine—BCHE—vagina—acquired immunodeficiency syndrome	0.000195	0.0357	CbGeAlD
Rivastigmine—BCHE—lung—acquired immunodeficiency syndrome	0.000184	0.0337	CbGeAlD
Rivastigmine—BCHE—nervous system—acquired immunodeficiency syndrome	0.000171	0.0312	CbGeAlD
Rivastigmine—BCHE—central nervous system—acquired immunodeficiency syndrome	0.000164	0.0301	CbGeAlD
Rivastigmine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000149	0.0272	CbGeAlD
Rivastigmine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000146	0.0267	CbGeAlD
Rivastigmine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000142	0.0259	CbGeAlD
Rivastigmine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000139	0.0255	CbGeAlD
Rivastigmine—BCHE—brain—acquired immunodeficiency syndrome	0.000131	0.0239	CbGeAlD
Rivastigmine—BCHE—lymph node—acquired immunodeficiency syndrome	0.000126	0.0231	CbGeAlD
Rivastigmine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000115	0.021	CbGeAlD
Rivastigmine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000113	0.0207	CbGeAlD
Rivastigmine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000111	0.0202	CbGeAlD
Rivastigmine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000109	0.0199	CbGeAlD
Rivastigmine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000299	CcSEcCtD
Rivastigmine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000299	CcSEcCtD
Rivastigmine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.000299	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000298	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	9.99e-05	0.000297	CcSEcCtD
Rivastigmine—Pruritus—Abacavir—acquired immunodeficiency syndrome	9.98e-05	0.000297	CcSEcCtD
Rivastigmine—Fatigue—Indinavir—acquired immunodeficiency syndrome	9.98e-05	0.000297	CcSEcCtD
Rivastigmine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	9.97e-05	0.000297	CcSEcCtD
Rivastigmine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	9.97e-05	0.000297	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	9.96e-05	0.000297	CcSEcCtD
Rivastigmine—Cough—Saquinavir—acquired immunodeficiency syndrome	9.96e-05	0.000296	CcSEcCtD
Rivastigmine—Pain—Indinavir—acquired immunodeficiency syndrome	9.9e-05	0.000295	CcSEcCtD
Rivastigmine—Constipation—Indinavir—acquired immunodeficiency syndrome	9.9e-05	0.000295	CcSEcCtD
Rivastigmine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	9.89e-05	0.000294	CcSEcCtD
Rivastigmine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	9.89e-05	0.000294	CcSEcCtD
Rivastigmine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	9.88e-05	0.000294	CcSEcCtD
Rivastigmine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	9.87e-05	0.000294	CcSEcCtD
Rivastigmine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	9.85e-05	0.000293	CcSEcCtD
Rivastigmine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	9.84e-05	0.000293	CcSEcCtD
Rivastigmine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	9.84e-05	0.000293	CcSEcCtD
Rivastigmine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	9.83e-05	0.000292	CcSEcCtD
Rivastigmine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	9.82e-05	0.000292	CcSEcCtD
Rivastigmine—Malaise—Lamivudine—acquired immunodeficiency syndrome	9.81e-05	0.000292	CcSEcCtD
Rivastigmine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	9.8e-05	0.000292	CcSEcCtD
Rivastigmine—Nausea—Didanosine—acquired immunodeficiency syndrome	9.79e-05	0.000292	CcSEcCtD
Rivastigmine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	9.78e-05	0.000291	CcSEcCtD
Rivastigmine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	9.78e-05	0.000291	CcSEcCtD
Rivastigmine—Syncope—Lamivudine—acquired immunodeficiency syndrome	9.76e-05	0.000291	CcSEcCtD
Rivastigmine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	9.75e-05	0.00029	CcSEcCtD
Rivastigmine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	9.75e-05	0.00029	CcSEcCtD
Rivastigmine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	9.72e-05	0.000289	CcSEcCtD
Rivastigmine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	9.71e-05	0.000289	CcSEcCtD
Rivastigmine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	9.71e-05	0.000289	CcSEcCtD
Rivastigmine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	9.71e-05	0.000289	CcSEcCtD
Rivastigmine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	9.68e-05	0.000288	CcSEcCtD
Rivastigmine—Oedema—Ritonavir—acquired immunodeficiency syndrome	9.67e-05	0.000288	CcSEcCtD
Rivastigmine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	9.65e-05	0.000287	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	9.65e-05	0.000287	CcSEcCtD
Rivastigmine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	9.62e-05	0.000287	CcSEcCtD
Rivastigmine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	9.6e-05	0.000286	CcSEcCtD
Rivastigmine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	9.57e-05	0.000285	CcSEcCtD
Rivastigmine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	9.54e-05	0.000284	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	9.53e-05	0.000284	CcSEcCtD
Rivastigmine—Shock—Ritonavir—acquired immunodeficiency syndrome	9.52e-05	0.000283	CcSEcCtD
Rivastigmine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	9.5e-05	0.000283	CcSEcCtD
Rivastigmine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	9.5e-05	0.000283	CcSEcCtD
Rivastigmine—Cough—Lamivudine—acquired immunodeficiency syndrome	9.5e-05	0.000283	CcSEcCtD
Rivastigmine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	9.5e-05	0.000283	CcSEcCtD
Rivastigmine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	9.49e-05	0.000282	CcSEcCtD
Rivastigmine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	9.47e-05	0.000282	CcSEcCtD
Rivastigmine—Dizziness—Stavudine—acquired immunodeficiency syndrome	9.47e-05	0.000282	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	9.46e-05	0.000282	CcSEcCtD
Rivastigmine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	9.46e-05	0.000282	CcSEcCtD
Rivastigmine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	9.44e-05	0.000281	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	9.44e-05	0.000281	CcSEcCtD
Rivastigmine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	9.43e-05	0.000281	CcSEcCtD
Rivastigmine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	9.43e-05	0.000281	CcSEcCtD
Rivastigmine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	9.43e-05	0.000281	CcSEcCtD
Rivastigmine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	9.4e-05	0.00028	CcSEcCtD
Rivastigmine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	9.39e-05	0.00028	CcSEcCtD
Rivastigmine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	9.39e-05	0.000279	CcSEcCtD
Rivastigmine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	9.35e-05	0.000278	CcSEcCtD
Rivastigmine—Constipation—Efavirenz—acquired immunodeficiency syndrome	9.35e-05	0.000278	CcSEcCtD
Rivastigmine—Pain—Efavirenz—acquired immunodeficiency syndrome	9.35e-05	0.000278	CcSEcCtD
Rivastigmine—Rash—Nevirapine—acquired immunodeficiency syndrome	9.35e-05	0.000278	CcSEcCtD
Rivastigmine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	9.34e-05	0.000278	CcSEcCtD
Rivastigmine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	9.33e-05	0.000278	CcSEcCtD
Rivastigmine—Dizziness—Abacavir—acquired immunodeficiency syndrome	9.33e-05	0.000278	CcSEcCtD
Rivastigmine—Oedema—Saquinavir—acquired immunodeficiency syndrome	9.31e-05	0.000277	CcSEcCtD
Rivastigmine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	9.3e-05	0.000277	CcSEcCtD
Rivastigmine—Headache—Nevirapine—acquired immunodeficiency syndrome	9.29e-05	0.000277	CcSEcCtD
Rivastigmine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	9.27e-05	0.000276	CcSEcCtD
Rivastigmine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	9.27e-05	0.000276	CcSEcCtD
Rivastigmine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	9.27e-05	0.000276	CcSEcCtD
Rivastigmine—Infection—Saquinavir—acquired immunodeficiency syndrome	9.25e-05	0.000275	CcSEcCtD
Rivastigmine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	9.23e-05	0.000275	CcSEcCtD
Rivastigmine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	9.22e-05	0.000275	CcSEcCtD
Rivastigmine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	9.21e-05	0.000274	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	9.2e-05	0.000274	CcSEcCtD
Rivastigmine—Urticaria—Indinavir—acquired immunodeficiency syndrome	9.19e-05	0.000274	CcSEcCtD
Rivastigmine—Shock—Saquinavir—acquired immunodeficiency syndrome	9.16e-05	0.000273	CcSEcCtD
Rivastigmine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	9.15e-05	0.000273	CcSEcCtD
Rivastigmine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	9.15e-05	0.000272	CcSEcCtD
Rivastigmine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	9.15e-05	0.000272	CcSEcCtD
Rivastigmine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	9.13e-05	0.000272	CcSEcCtD
Rivastigmine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	9.13e-05	0.000272	CcSEcCtD
Rivastigmine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	9.12e-05	0.000271	CcSEcCtD
Rivastigmine—Vomiting—Stavudine—acquired immunodeficiency syndrome	9.1e-05	0.000271	CcSEcCtD
Rivastigmine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	9.09e-05	0.000271	CcSEcCtD
Rivastigmine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	9.06e-05	0.00027	CcSEcCtD
Rivastigmine—Rash—Nelfinavir—acquired immunodeficiency syndrome	9.05e-05	0.00027	CcSEcCtD
Rivastigmine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	9.05e-05	0.000269	CcSEcCtD
Rivastigmine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	9.04e-05	0.000269	CcSEcCtD
Rivastigmine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	9.04e-05	0.000269	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	9.03e-05	0.000269	CcSEcCtD
Rivastigmine—Rash—Stavudine—acquired immunodeficiency syndrome	9.03e-05	0.000269	CcSEcCtD
Rivastigmine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	9.02e-05	0.000268	CcSEcCtD
Rivastigmine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	9.02e-05	0.000268	CcSEcCtD
Rivastigmine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	9.01e-05	0.000268	CcSEcCtD
Rivastigmine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	9e-05	0.000268	CcSEcCtD
Rivastigmine—Headache—Nelfinavir—acquired immunodeficiency syndrome	9e-05	0.000268	CcSEcCtD
Rivastigmine—Headache—Stavudine—acquired immunodeficiency syndrome	8.97e-05	0.000267	CcSEcCtD
Rivastigmine—Vomiting—Abacavir—acquired immunodeficiency syndrome	8.97e-05	0.000267	CcSEcCtD
Rivastigmine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	8.96e-05	0.000267	CcSEcCtD
Rivastigmine—Pain—Delavirdine—acquired immunodeficiency syndrome	8.95e-05	0.000266	CcSEcCtD
Rivastigmine—Constipation—Delavirdine—acquired immunodeficiency syndrome	8.95e-05	0.000266	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	8.94e-05	0.000266	CcSEcCtD
Rivastigmine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	8.93e-05	0.000266	CcSEcCtD
Rivastigmine—Rash—Abacavir—acquired immunodeficiency syndrome	8.89e-05	0.000265	CcSEcCtD
Rivastigmine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	8.88e-05	0.000264	CcSEcCtD
Rivastigmine—Oedema—Lamivudine—acquired immunodeficiency syndrome	8.88e-05	0.000264	CcSEcCtD
Rivastigmine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	8.88e-05	0.000264	CcSEcCtD
Rivastigmine—Headache—Abacavir—acquired immunodeficiency syndrome	8.84e-05	0.000263	CcSEcCtD
Rivastigmine—Infection—Lamivudine—acquired immunodeficiency syndrome	8.82e-05	0.000263	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	8.81e-05	0.000262	CcSEcCtD
Rivastigmine—Nausea—Nevirapine—acquired immunodeficiency syndrome	8.81e-05	0.000262	CcSEcCtD
Rivastigmine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	8.8e-05	0.000262	CcSEcCtD
Rivastigmine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	8.75e-05	0.00026	CcSEcCtD
Rivastigmine—Shock—Lamivudine—acquired immunodeficiency syndrome	8.74e-05	0.00026	CcSEcCtD
Rivastigmine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	8.71e-05	0.000259	CcSEcCtD
Rivastigmine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	8.7e-05	0.000259	CcSEcCtD
Rivastigmine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	8.7e-05	0.000259	CcSEcCtD
Rivastigmine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	8.69e-05	0.000259	CcSEcCtD
Rivastigmine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	8.69e-05	0.000259	CcSEcCtD
Rivastigmine—CYP2D6—brain—acquired immunodeficiency syndrome	8.65e-05	0.0158	CbGeAlD
Rivastigmine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	8.64e-05	0.000257	CcSEcCtD
Rivastigmine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	8.64e-05	0.000257	CcSEcCtD
Rivastigmine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	8.63e-05	0.000257	CcSEcCtD
Rivastigmine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	8.62e-05	0.000257	CcSEcCtD
Rivastigmine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	8.62e-05	0.000257	CcSEcCtD
Rivastigmine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	8.6e-05	0.000256	CcSEcCtD
Rivastigmine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	8.59e-05	0.000256	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	8.55e-05	0.000255	CcSEcCtD
Rivastigmine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	8.53e-05	0.000254	CcSEcCtD
Rivastigmine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	8.53e-05	0.000254	CcSEcCtD
Rivastigmine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	8.52e-05	0.000254	CcSEcCtD
Rivastigmine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	8.51e-05	0.000253	CcSEcCtD
Rivastigmine—Nausea—Stavudine—acquired immunodeficiency syndrome	8.5e-05	0.000253	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	8.48e-05	0.000253	CcSEcCtD
Rivastigmine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	8.47e-05	0.000252	CcSEcCtD
Rivastigmine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	8.42e-05	0.000251	CcSEcCtD
Rivastigmine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	8.41e-05	0.00025	CcSEcCtD
Rivastigmine—Nausea—Abacavir—acquired immunodeficiency syndrome	8.38e-05	0.000249	CcSEcCtD
Rivastigmine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	8.36e-05	0.000249	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	8.35e-05	0.000249	CcSEcCtD
Rivastigmine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	8.34e-05	0.000248	CcSEcCtD
Rivastigmine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	8.31e-05	0.000247	CcSEcCtD
Rivastigmine—Asthenia—Indinavir—acquired immunodeficiency syndrome	8.3e-05	0.000247	CcSEcCtD
Rivastigmine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	8.3e-05	0.000247	CcSEcCtD
Rivastigmine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	8.3e-05	0.000247	CcSEcCtD
Rivastigmine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	8.28e-05	0.000246	CcSEcCtD
Rivastigmine—Pain—Ritonavir—acquired immunodeficiency syndrome	8.27e-05	0.000246	CcSEcCtD
Rivastigmine—Constipation—Ritonavir—acquired immunodeficiency syndrome	8.27e-05	0.000246	CcSEcCtD
Rivastigmine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	8.27e-05	0.000246	CcSEcCtD
Rivastigmine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	8.27e-05	0.000246	CcSEcCtD
Rivastigmine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	8.23e-05	0.000245	CcSEcCtD
Rivastigmine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	8.2e-05	0.000244	CcSEcCtD
Rivastigmine—Pruritus—Indinavir—acquired immunodeficiency syndrome	8.19e-05	0.000244	CcSEcCtD
Rivastigmine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	8.09e-05	0.000241	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	8.09e-05	0.000241	CcSEcCtD
Rivastigmine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	8.06e-05	0.00024	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	8.04e-05	0.000239	CcSEcCtD
Rivastigmine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	8.03e-05	0.000239	CcSEcCtD
Rivastigmine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	8.03e-05	0.000239	CcSEcCtD
Rivastigmine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	7.98e-05	0.000237	CcSEcCtD
Rivastigmine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	7.97e-05	0.000237	CcSEcCtD
Rivastigmine—Pain—Saquinavir—acquired immunodeficiency syndrome	7.96e-05	0.000237	CcSEcCtD
Rivastigmine—Constipation—Saquinavir—acquired immunodeficiency syndrome	7.96e-05	0.000237	CcSEcCtD
Rivastigmine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	7.92e-05	0.000236	CcSEcCtD
Rivastigmine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	7.92e-05	0.000236	CcSEcCtD
Rivastigmine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	7.91e-05	0.000236	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	7.91e-05	0.000235	CcSEcCtD
Rivastigmine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	7.9e-05	0.000235	CcSEcCtD
Rivastigmine—Rash—Zidovudine—acquired immunodeficiency syndrome	7.85e-05	0.000234	CcSEcCtD
Rivastigmine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	7.84e-05	0.000234	CcSEcCtD
Rivastigmine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	7.84e-05	0.000233	CcSEcCtD
Rivastigmine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	7.82e-05	0.000233	CcSEcCtD
Rivastigmine—Headache—Zidovudine—acquired immunodeficiency syndrome	7.8e-05	0.000232	CcSEcCtD
Rivastigmine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	7.74e-05	0.00023	CcSEcCtD
Rivastigmine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	7.72e-05	0.00023	CcSEcCtD
Rivastigmine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	7.71e-05	0.000229	CcSEcCtD
Rivastigmine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	7.69e-05	0.000229	CcSEcCtD
Rivastigmine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	7.67e-05	0.000228	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	7.67e-05	0.000228	CcSEcCtD
Rivastigmine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	7.66e-05	0.000228	CcSEcCtD
Rivastigmine—Dizziness—Indinavir—acquired immunodeficiency syndrome	7.65e-05	0.000228	CcSEcCtD
Rivastigmine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	7.65e-05	0.000228	CcSEcCtD
Rivastigmine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	7.65e-05	0.000228	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	7.61e-05	0.000227	CcSEcCtD
Rivastigmine—Pain—Lamivudine—acquired immunodeficiency syndrome	7.6e-05	0.000226	CcSEcCtD
Rivastigmine—Constipation—Lamivudine—acquired immunodeficiency syndrome	7.6e-05	0.000226	CcSEcCtD
Rivastigmine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	7.51e-05	0.000223	CcSEcCtD
Rivastigmine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	7.48e-05	0.000223	CcSEcCtD
Rivastigmine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	7.4e-05	0.00022	CcSEcCtD
Rivastigmine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	7.4e-05	0.00022	CcSEcCtD
Rivastigmine—Nausea—Zidovudine—acquired immunodeficiency syndrome	7.39e-05	0.00022	CcSEcCtD
Rivastigmine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	7.36e-05	0.000219	CcSEcCtD
Rivastigmine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	7.36e-05	0.000219	CcSEcCtD
Rivastigmine—Vomiting—Indinavir—acquired immunodeficiency syndrome	7.36e-05	0.000219	CcSEcCtD
Rivastigmine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	7.32e-05	0.000218	CcSEcCtD
Rivastigmine—Rash—Indinavir—acquired immunodeficiency syndrome	7.3e-05	0.000217	CcSEcCtD
Rivastigmine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	7.29e-05	0.000217	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	7.26e-05	0.000216	CcSEcCtD
Rivastigmine—Headache—Indinavir—acquired immunodeficiency syndrome	7.25e-05	0.000216	CcSEcCtD
Rivastigmine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	7.23e-05	0.000215	CcSEcCtD
Rivastigmine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	7.16e-05	0.000213	CcSEcCtD
Rivastigmine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	7.13e-05	0.000212	CcSEcCtD
Rivastigmine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	7.06e-05	0.00021	CcSEcCtD
Rivastigmine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	7.02e-05	0.000209	CcSEcCtD
Rivastigmine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	7.02e-05	0.000209	CcSEcCtD
Rivastigmine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	6.95e-05	0.000207	CcSEcCtD
Rivastigmine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	6.94e-05	0.000207	CcSEcCtD
Rivastigmine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	6.92e-05	0.000206	CcSEcCtD
Rivastigmine—Rash—Efavirenz—acquired immunodeficiency syndrome	6.89e-05	0.000205	CcSEcCtD
Rivastigmine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	6.89e-05	0.000205	CcSEcCtD
Rivastigmine—Nausea—Indinavir—acquired immunodeficiency syndrome	6.87e-05	0.000205	CcSEcCtD
Rivastigmine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	6.86e-05	0.000204	CcSEcCtD
Rivastigmine—Headache—Efavirenz—acquired immunodeficiency syndrome	6.85e-05	0.000204	CcSEcCtD
Rivastigmine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	6.84e-05	0.000204	CcSEcCtD
Rivastigmine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	6.68e-05	0.000199	CcSEcCtD
Rivastigmine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	6.65e-05	0.000198	CcSEcCtD
Rivastigmine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	6.62e-05	0.000197	CcSEcCtD
Rivastigmine—Rash—Delavirdine—acquired immunodeficiency syndrome	6.6e-05	0.000196	CcSEcCtD
Rivastigmine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	6.59e-05	0.000196	CcSEcCtD
Rivastigmine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	6.59e-05	0.000196	CcSEcCtD
Rivastigmine—Headache—Delavirdine—acquired immunodeficiency syndrome	6.55e-05	0.000195	CcSEcCtD
Rivastigmine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	6.54e-05	0.000195	CcSEcCtD
Rivastigmine—Nausea—Efavirenz—acquired immunodeficiency syndrome	6.49e-05	0.000193	CcSEcCtD
Rivastigmine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	6.4e-05	0.00019	CcSEcCtD
Rivastigmine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	6.37e-05	0.00019	CcSEcCtD
Rivastigmine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	6.37e-05	0.00019	CcSEcCtD
Rivastigmine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	6.28e-05	0.000187	CcSEcCtD
Rivastigmine—Nausea—Delavirdine—acquired immunodeficiency syndrome	6.21e-05	0.000185	CcSEcCtD
Rivastigmine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	6.16e-05	0.000183	CcSEcCtD
Rivastigmine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	6.15e-05	0.000183	CcSEcCtD
Rivastigmine—Rash—Ritonavir—acquired immunodeficiency syndrome	6.1e-05	0.000182	CcSEcCtD
Rivastigmine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	6.09e-05	0.000181	CcSEcCtD
Rivastigmine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	6.08e-05	0.000181	CcSEcCtD
Rivastigmine—Headache—Ritonavir—acquired immunodeficiency syndrome	6.06e-05	0.00018	CcSEcCtD
Rivastigmine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	5.92e-05	0.000176	CcSEcCtD
Rivastigmine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	5.87e-05	0.000175	CcSEcCtD
Rivastigmine—Rash—Saquinavir—acquired immunodeficiency syndrome	5.87e-05	0.000175	CcSEcCtD
Rivastigmine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	5.87e-05	0.000175	CcSEcCtD
Rivastigmine—Headache—Saquinavir—acquired immunodeficiency syndrome	5.83e-05	0.000174	CcSEcCtD
Rivastigmine—Nausea—Ritonavir—acquired immunodeficiency syndrome	5.75e-05	0.000171	CcSEcCtD
Rivastigmine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	5.65e-05	0.000168	CcSEcCtD
Rivastigmine—Rash—Lamivudine—acquired immunodeficiency syndrome	5.6e-05	0.000167	CcSEcCtD
Rivastigmine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	5.6e-05	0.000167	CcSEcCtD
Rivastigmine—Headache—Lamivudine—acquired immunodeficiency syndrome	5.56e-05	0.000166	CcSEcCtD
Rivastigmine—Nausea—Saquinavir—acquired immunodeficiency syndrome	5.53e-05	0.000165	CcSEcCtD
Rivastigmine—Nausea—Lamivudine—acquired immunodeficiency syndrome	5.28e-05	0.000157	CcSEcCtD
